Century Therapeutics Inc reports results for the quarter ended in June - Earnings Summary

Century Therapeutics

12/08/2021 15:07

* Century Therapeutics Inc  IPSC.OQ  reported a quarterly
adjusted loss of $1.93​​ per share for the quarter ended in
June. The mean expectation of three analysts for the quarter was
for a loss of 42 cents per share.
* Reported revenue was zero​;  analysts expected zero. 
* Century Therapeutics Inc's reported EPS for the quarter was a
loss of $1.93​.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Century Therapeutics Inc shares had risen by 6.0% this
quarter.
* The company reported a quarterly loss of $23.27 million.
* Wall Street's median 12-month price target for Century
Therapeutics Inc is $38.00 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
This summary was machine generated August 12 at 02:07 p.m.  ​All
figures in US dollars unless otherwise stated